Bubble fears grow amid glut of IPOs in the US by early-stage biotechs
Dicerna Pharmaceuticals a focal point of concern as it has yet to enter clinical trials and refused to impose share sale block on major shareholders
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices